Evidence map›Paper›PMID 27743225›Full record

ArticleAnnals of surgical oncology2017

Establishing a Cancer Research Consortium in Low- and Middle-Income Countries: Challenges Faced and Lessons Learned.

Sara E Fischer, Olusegun I Alatise, Akinwunmi O Komolafe, Aba I Katung, Adedeji A Egberongbe, Samuel A Olatoke, Olayide S Agodirin, Oladapo A Kolawole, Olaejerinde O Olaofe, Omobolaji O Ayandipo and 3 more

Abstract read
In one paragraph

Article in Annals of surgical oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. POSNA-POGO Scholars Research Initiative: Capacity and Needs.Journal of the Pediatric Orthopaedic Society of North America · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Tale of Two Fellows.Journal of global oncology · 2017
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sara E FischerMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Olusegun I AlatiseObafemi Awolowo University, Ile-Ife, Nigeria.
Akinwunmi O KomolafeObafemi Awolowo University, Ile-Ife, Nigeria.
Aba I KatungFederal Medical Center, Owo, Nigeria.
Adedeji A EgberongbeFederal Medical Center, Owo, Nigeria.
Samuel A OlatokeUniversity of Ilorin Teaching Hospital, Ilorin, Nigeria.
Olayide S AgodirinUniversity of Ilorin Teaching Hospital, Ilorin, Nigeria.
Oladapo A KolawoleLadoke Akintola University Teaching Hospital, Osogbo, Nigeria.
Olaejerinde O OlaofeLadoke Akintola University Teaching Hospital, Osogbo, Nigeria.
Omobolaji O AyandipoUniversity College Hospital, Ibadan, Nigeria.
Olorunda RotimiSt. James University Hospital, Leeds, UK.
Murray F BrennanMemorial Sloan Kettering Cancer Center, New York, NY, USA.
T Peter KinghamMemorial Sloan Kettering Cancer Center, New York, NY, USA. kinghamt@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeThere is an increasing effort in the global public health community to strengthen research capacity in low- and middle-income countries, but there is no consensus on how best to approach such endeavors. Successful consortia that perform research on HIV/AIDS and other infectious diseases exist, but few papers have been published detailing the challenges faced and lessons learned in setting up and running a successful research consortium.

methodsMembers of the African Research Group for Oncology (ARGO) participated in generating lessons learned regarding the foundation and maintenance of a cancer research consortium in Nigeria.

resultsDrawing on our experience of founding ARGO, we describe steps and key factors needed to establish a successful collaborative consortium between researchers from both high- and low-income countries. In addition, we present challenges we encountered in building our consortium, and how we managed those challenges. Although our research group is focused primarily on cancer, many of our lessons learned can be applied more widely in biomedical or public health research in low-income countries.

conclusionsAs the need for cancer care in LMICs continues to grow, the ability to create sustainable, innovative, collaborative research groups will become vital. Assessing the successes and failures that occur in creating and sustaining research consortia in LMICs is important for expansion of research and training capacity in LMICs.

Indexed as

Developing CountriesNeoplasmsBiomedical ResearchCapacity BuildingCooperative BehaviorHumansInternational CooperationNigeriaOrganizationsProgram DevelopmentWorkforce

Identifiers

PMID27743225
PMCPMC5364494

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.